logo
Indiana passes law threatening non-profit status of expensive hospitals

Indiana passes law threatening non-profit status of expensive hospitals

The Guardian09-05-2025

Indiana's governor, Mike Braun, has signed a landmark bill that would strip charity hospitals of their non-profit status if they continue to charge high prices.
The legislation, the first of its kind in the United States, followed uproar across the state after a Guardian series in October that investigated how one major Indiana non-profit hospital system bought up its competition, then hiked its prices, leaving businesses and patients struggling to pay their medical costs.
In the wake of the Guardian investigation, Braun, then the Republican gubernatorial candidate, and his Democratic rival both criticized the hospital system, Parkview Health, for its high prices, and lawmakers vowed to take action against the non-profit chain, which charged some of the highest prices in the country despite being based in Fort Wayne, Indiana, the US's most affordable metro area.
Braun signed the legislation into law on Tuesday. It comes at a time of growing concern across the US about healthcare costs and medical debt.
To implement the law, the Indiana office of management and budget will first study prices across the state and come up with a price benchmark for non-profit hospitals in consultation with the legislature, according to the bill's author, Martin Carbaugh, a Republican representative who represents a district that includes Fort Wayne. Non-profit hospitals will then have until 2029 to get their prices under that average, though Carbaugh hopes some will lower their prices before then as they negotiate with insurers.
'We'll start to see the downward pressure put on them right away,' he said. 'The hospitals know they can't just go for broke and raise costs, only to have to lower it again in 2029.'
According to data compiled by Hoosiers for Affordable Healthcare, an Indiana advocacy group, the legislation could result in average price reductions as large as 40% for Parkview, and similarly sized cuts for other large state hospital systems.
'It's gonna be beneficial to everybody,' said Doug Allen, a small business owner who has struggled to keep up with Parkview's healthcare costs for his employees. 'Maybe people won't be hurting so bad. Maybe they won't think twice before coming to the hospital. Almost everybody around here is on a payment plan with Parkview. Everybody owes money to Parkview.'
Parkview Health did not respond to requests for comment but has previously said it is committed to lowering healthcare costs.
In a statement, the Indiana Hospital Association said it was 'concerned by the potential loss of non-profit status for hospitals based on meeting an unknown statewide average commercial price in the future. This does not take into consideration the uncertainty of rising cost pressures such as tariffs, inflation, and other significant economic factors that will further threaten the financial stability of Indiana's health care ecosystem.'
The group added that it looks forward to 'continuing our work with legislators and Gov Braun's administration on future solutions that strike the right balance of lowering costs while maintaining access for Hoosier patients'.
The US spends far more on healthcare than other large, wealthy countries, a trend that has been exacerbated by decades of hospital consolidation limiting competition in the healthcare sector.
Carbaugh said he was aware of how high healthcare prices are across the country and said Indiana's legislation might be a model for other states too.
'It's great to be a leader,' he said. 'I'm happy to be part of leading that charge.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Woman, 31, adds name to euthanasia list after ‘grim' cancer diagnosis – then she receives ‘haunting' realisation
Woman, 31, adds name to euthanasia list after ‘grim' cancer diagnosis – then she receives ‘haunting' realisation

The Sun

time25 minutes ago

  • The Sun

Woman, 31, adds name to euthanasia list after ‘grim' cancer diagnosis – then she receives ‘haunting' realisation

A WOMAN who was told she had advanced-stage breast cancer and only months to live received shocking news just days later. Gabriella Patey, 31, received the "grim diagnosis" that had also claimed her mum's life, and began telling family and friends, as well as making end-of-life preparations. 2 2 Living in Canada, Gabriella put a claim through her bank for critical illness insurance and put her name on the list for medically assisted dying. She told Global News: "I just came to terms with it. This is what it was, just absolutely devastating." But just says later, her family doctor called with some unbelievable news. She recalled: "I got another call from my primary care physician stating, actually, there had been a critical patient error at the IWK (Health Centre). "And the file with the grim diagnosis did not even belong to me. "I didn't even really believe her. I mean why should I? They had made this mistake once, how could they make it again?" Gabriella first discovered a lump on her breast in October 2023, not long after her mum had died of the disease. Over the course of a year, she had multiple ultrasounds at the Breast Health Clinic at the IWK Health Centre in Halifax, Nova Scotia. In May 17, following a biopsy, Gabriella received the "great news" there were no traces of breast cancer. But two and a half weeks later, her family doctor called to say there must have been mistake as she did actually have cancer. I planned my suicide after my GP misdiagnosed me - turns out I wasn't depressed The news came just five days after she'd finished successful treatment for thyroid cancer. Two days later, however, her family doctor confirmed it was actually an error - she didn't have cancer. Gabriella's doctor went to the IWK to check her lab report. She said: "A director in the pathology department spoke to my primary care physician verbally admitted that it was a critical patient error." While Gabriella has received an apology from IWK, she's been left doubting Nova Scotia's health-care system and is pursuing legal action. She said she and her family have been left haunted by what's happened. 'It's absolutely devastating to get a diagnosis like that. I had to look my husband in the face and tell him,' she said. '(We have) all these plans for our future and (I had to) say, 'I may not be here to live out those plans with you.' I mean we're crying ourselves to sleep every night.' In a statement to Global News, a spokesperson from IWK Health said "concerns of this nature are taken seriously." Spokesperson Andrea Slaney wrote: "Due to patient privacy, IWK Health is unable to comment on specific cases. "However, concerns of this nature are taken seriously and a formal investigation process is followed with engagement from IWK's Quality, Patient Safety and Patient Experience team."

Contrave vs. Wegovy: What to know about each
Contrave vs. Wegovy: What to know about each

Medical News Today

time26 minutes ago

  • Medical News Today

Contrave vs. Wegovy: What to know about each

Contrave (naltrexone/bupropion) and Wegovy (semaglutide) are brand-name drugs. They're both prescribed for weight loss in adults. This article explains the main similarities and differences between Contrave and Wegovy. If you're considering taking one of these drugs, discussing this information with your doctor can help you decide whether one of these treatments may be right for you. Note: For more comprehensive information about these two drugs, you can refer to our Contrave and Wegovy articles. These are a few of the main differences between Contrave and Wegovy: Form: Contrave comes as an extended-release oral tablet, while Wegovy is a solution in prefilled, single-use pens that administer the medication as a subcutaneous injection. ('Extended-release' means the drug slowly releases into your body over a long period of time.) Contrave comes as an extended-release oral tablet, while Wegovy is a solution in prefilled, single-use pens that administer the medication as a subcutaneous injection. ('Extended-release' means the drug slowly releases into your body over a long period of time.) Dosage : Contrave is taken more often than Wegovy. (See the Dosage section.) : Contrave is taken more often than Wegovy. (See the Dosage section.) Conditions treated: Contrave and Wegovy are both used for weight loss in certain adults, but Wegovy is also used for weight management in certain children and to lower certain cardiovascular risks in certain adults. (See the Uses section.) Contrave and Wegovy have been approved by the Food and Drug Administration (FDA) for the following uses in adults, in combination with exercise and a reduced-calorie diet. Contrave and Wegovy are FDA approved for: Wegovy is also FDA approved to: lower the risk of serious cardiovascular (heart and blood vessel) events, including non-fatal heart attack or stroke, in adults with cardiovascular disease, or who have obesity or are considered overweight Wegovy is approved for weight loss and management in children ages 12 years and older with obesity, usually defined as a BMI of 30 kg/m2 or greater. Contrave is not approved for use in children. The medication has a boxed warning that includes a note that it has not been studied in children. To learn more about this warning, see 'Precautions for Contrave and Wegovy'. Note: For more information about the drugs' uses, see our articles about Contrave and Wegovy. Here's a quick look at the dosage and administration of Contrave and Wegovy for the conditions they treat. Below is information on Contrave and Wegovy dosages for weight management in adults. Wegovy comes as a solution inside prefilled, single-use pens given as a subcutaneous injection. When you're first prescribed Wegovy, a healthcare professional will show you how to give yourself the injections. You can also refer to the 'How to Take Wegovy' guide from the manufacturer. Note: For more information about dosage, see our dosage articles about Contrave and Wegovy. Contrave and Wegovy are both used for weight management in certain adults. These drugs can cause some of the same side effects, as well as different ones. Some of the side effects reported in clinical trials of these drugs are listed here. The following table lists some of the more commonly reported mild side effects of Contrave and Wegovy. The table may also include mild side effects that are less common, but you may have concerns about them in some cases. These side effects may be temporary, lasting a few days to weeks. If the side effects last longer than that, bother you, or become severe, be sure to talk with your doctor or pharmacist. The following table lists reported serious side effects of Contrave and Wegovy. If you have serious side effects while using Contrave or Wegovy, call your doctor immediately. If the side effects feel life threatening or you believe you're having a medical emergency, call 911 or your local emergency number right away. * Contrave has a boxed warning for this side effect. A boxed warning is a serious warning from the FDA. To learn more, see the 'Precautions for Contrave and Wegovy' section. ** Wegovy has a boxed warning for this side effect. A boxed warning is a serious warning from the FDA. To learn more, see the 'Precautions for Contrave and Wegovy' section. ALLERGIC REACTION For some people, Contrave and Wegovy can cause an allergic reaction. In general, symptoms of an allergic reaction can be mild or serious. Ways to manage For mild allergic reaction symptoms, such as a mild rash, call your doctor right away. They may recommend treatments to help manage your symptoms. They'll also let you know whether you should keep taking the medication. For severe allergic reaction symptoms, such as swelling or trouble breathing, call 911 or your local emergency number right away. These symptoms require immediate medical care because they can become life threatening. If you've had a serious allergic reaction to Contrave, your doctor may recommend taking a different medication instead. Here are answers to some common questions about Contrave and Wegovy. It's not clear. Currently, there aren't enough studies evaluating whether it's safe to take Contrave and Wegovy for weight loss together or if taking them together is more effective for weight loss and management than taking either medication on their own. In fact, the prescribing information for Contrave specifically notes that it hasn't been studied in combination with other medications for weight loss. Due to the lack of evidence, your doctor may not prescribe Contrave and Wegovy together. Contrave and Wegovy can cause some similar side effects, including increased heart rate. Taking them together may further raise your risk for certain side effects caused by both medications. Talk with your doctor if you're thinking about taking Wegovy or Contrave for weight loss. They can help determine the best treatment plan for you. You may wonder how Wegovy and Contrave compare to Ozempic, Qsymia, Saxenda, and similar medications. The table below includes a few key details on how Contrave and Wegovy compare to similar drugs. It's important to note that some of these drugs are approved for different uses. Your doctor can help determine which of these medications is the best fit for you based on your treatment needs. Contrave and Wegovy are both FDA approved for: weight loss and management, in adults with a BMI of 30 kg/m 2 or greater, which indicates obesity or greater, which indicates obesity weight loss and management, in adults with a BMI of 27 kg/m2 or greater (which is considered overweight) who also have at least one weight-related condition, including high blood pressure, high cholesterol, or type 2 diabetes If you're considering treatment with either medication for these uses, you may wonder how their effectiveness compares. Prescribing information: Both Contrave and Wegovy were found to be effective for weight loss and management in certain adults in clinical trials. For details about how these drugs performed in clinical trials, see the prescribing information for Contrave and Wegovy. Keep in mind that trial results may not apply to your individual health situation. Treatment guidelines: Another way to determine whether a drug is considered effective is to look at treatment guidelines. When an organization includes certain drugs in treatment guidelines, this means research has shown the drug to be safe and effective. Both Contrave and Wegovy are recommended as a treatment option for weight loss and management in certain adults in guidelines from the American Gastroenterological Association. How much Contrave or Wegovy costs depends on the treatment plan your doctor prescribes, your insurance plan, and your pharmacy. You can visit Optum Perks for price estimates of Contrave and Wegovy. (Optum Perks is a sister site of Medical News Today.) Both Contrave and Wegovy are brand-name drugs. Neither Contrave nor Wegovy is available in a generic form. Brand-name medications often cost more than generics. Talk with your doctor or pharmacist to learn about the generic form of either drug. Contrave and Wegovy may not be right for you if you have certain medical conditions or other factors that affect your health. These drugs have some of the same precautions, but they also have different ones. Some of these precautions are mentioned here. Wegovy has a boxed warning for the risk of thyroid cancer. A boxed warning is a serious warning from the Food and Drug Administration (FDA). A boxed warning alerts doctors and patients about drug effects that may be dangerous. During treatment with Wegovy, let your doctor know if you have symptoms of thyroid tumors or cancer. Examples include a hoarse voice that doesn't go away, a mass or lump in your neck, and shortness of breath. Contrave has a boxed warning about the risk for suicidal thoughts and behaviors. Risk for suicidal thoughts and behaviors: Contrave contains bupropion as one of its active ingredients (what makes a drug work). Bupropion is an antidepressant, and antidepressants may cause a small increase in risk for suicidal thoughts and behaviors. This risk applies to children and adults ages 24 and under, based on a large review of studies evaluating short-term antidepressant use. It's important to note that Contrave is not approved for use in children. Contrave is also not approved for treating depression or any other mental health condition. In addition to boxed warnings, Contrave and Wegovy have other warnings. If any of the following medical conditions or other health factors are relevant to you, talk with your doctor before using Contrave or Wegovy. Note: For more comprehensive information about these drugs, you can refer to our Contrave and Wegovy articles. Switching between Contrave and Wegovy might be possible. Both Contrave and Wegovy are approved for weight loss and management, along with diet and exercise, in certain adults. If you're taking Wegovy to lower your risk for certain cardiovascular problems, your doctor likely will not switch you to Contrave for this use. This isn't an approved use for Contrave. If you'd like to know more about switching between Contrave and Wegovy, talk with your doctor. They can give you additional details and help determine the best course of action for your personal situation. Even if two drugs treat the same condition or are in the same drug class, your body can still respond differently. It's important that you do not stop, start, or switch any of your drug treatments without your doctor's recommendation. Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses. Medical News Today has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources to ensure content accuracy and integrity. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.

Players undergoing fertility procedures to get protected ranking, says WTA
Players undergoing fertility procedures to get protected ranking, says WTA

Reuters

time33 minutes ago

  • Reuters

Players undergoing fertility procedures to get protected ranking, says WTA

June 11 (Reuters) - Female players who choose to undergo a fertility protection procedure will be allowed to take time away from the sport and return to competitive action with a protected ranking, the governing body of women's tennis (WTA) said on Wednesday. The new rule aims to support women athletes to balance their family goals and career ambitions and comes three months after the WTA offered players up to 12 months of paid maternity leave for the first time. "The new rule means that players can now take time away from professional tennis for a fertility protection procedure such as egg or embryo freezing and safely return to competition with a protected ranking," the WTA said in a statement. "Eligible players will receive a Special Entry Ranking (SER), which can be used to enter up to three tournaments, based on the 12-week average of their WTA Ranking from eight weeks prior to the start of their out-of-competition period." Sloane Stephens, the 2017 U.S. Open champion, has previously called for egg freezing to be recognised as a protected ranking activity and called Wednesday's announcement a "ground-breaking" move. "I'm incredibly proud of our sport in recognising the importance of fertility treatments for female athletes. For any woman, the conversation of family life versus a career is nuanced and complex," the former world number three said. "The WTA has now created a safe space for players to explore options and to make the best decisions for themselves." The WTA also said players will benefit from paid maternity leave and grants for fertility protection through the WTA Maternity Fund sponsored by the Saudi Public Investment Fund.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store